Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies.
about
Preliminary experience using directional coronary atherectomy for the treatment of acute myocardial infarction.Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy.Early interventions in the management of acute uncomplicated myocardial infarction.Comparison of diagnostic accuracy, time dependency, and prognostic impact of abnormal Q waves, combined electrocardiographic criteria, and ST segment abnormalities in right ventricular infarction.Defining the utility of clinically acceptable variations in evidence-based practice guidelines for evaluation of quality improvement activities.Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).Current status of thrombolytic therapy in acute myocardial infarctionImpact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction.Guidelines for the early management of patients with myocardial infarction. British Heart Foundation Working GroupLength of delay in seeking medical care by patients with heart failure symptoms and the role of symptom-related factors: a narrative review.Age-related variability in the use of cardiovascular imaging procedures.The use of percutaneous transluminal coronary angioplasty in myocardial infarction.Acute myocardial infarction treatments in 58 Italian hospitals: a drug utilization survey.Ejection fraction and mortality rate of patients with isolated acute inferior myocardial infarction reperfused by streptokinase.STENT IN ACUTE NON-Q WAVE MYOCARDIAL INFARCTION.Thrombolysis for Acute Myocardial Infarction: Early treatment can reduce mortality and morbidity.THROMBOLYSIS IN MYOCARDIAL INFARCTION.Audit of thrombolysis initiated in an accident and emergency department.Improving the management of acute myocardial infarction.Thrombolytic treatment.Mechanism of decreased adenosine protection in reperfusion injury of aging rats.Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction.Thrombolysis after acute myocardial infarction.Prognostic value of new-onset right bundle-branch block in acute myocardial infarction patients: a systematic review and meta-analysis.
P2860
Q33568618-41D414C6-04B6-4AFF-AC45-88CD204F93FEQ33578123-BC26DAD4-F944-4A21-A562-111E1EB6CB68Q33608022-D429707C-82B0-43FC-8479-8C2D59A6BCBFQ33613957-91B2201D-7A18-49F3-AA62-CDB68C2C35BBQ33772069-AE58534A-E5B1-4DDA-8192-87FC89D0BE1DQ35179710-07217621-EEDC-4EF8-B6BB-78612C9B9663Q35687099-24F4EDAF-985C-4AAF-A9F8-9D1875817A03Q36844116-0D0A2648-8DE6-4FD2-82F0-D2DD08F7C0EDQ36884538-CE46F77D-2CE7-45A0-96FB-CCA5441C038DQ37777889-7F2DD1F0-D0B4-4305-B801-2A3A485D57B9Q39410910-57ACA31B-D737-410F-859D-4721178CF0F6Q40493546-18FDA413-D1E4-4131-9DF5-96C837280365Q40952926-89EF6098-D359-415B-8915-CAA9C1C8E9EFQ41787373-A6422738-6074-4008-82B6-4B9BC22D0401Q41887650-35833D5E-AF46-4973-9239-9534F9BF186EQ42076519-A7DCEB21-3BDB-48FD-B70E-90D6B22D4297Q42337900-3F586558-6FCD-4337-9B14-C250DEE40D0CQ42682656-9DD6EFDB-A387-4FB6-8DBE-02CD87D781FEQ42780613-D1BC7CB6-BCA5-407D-A532-7660907715A0Q42878073-B0A4DFD2-800A-47D1-BDB1-119FF2145D33Q43505175-B28F7790-570A-4DAF-A2CE-3FAE5C504B3DQ43752026-5BC0B1D5-421B-414F-B3A2-911CAE203F47Q50009109-564A9937-81A3-4BDF-9C95-019AAF62B27BQ52632501-9B7F5631-B6BF-4B15-BCCD-2DB26E9825E7
P2860
Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Optimal utilization of thrombo ...... n: concepts and controversies.
@en
Optimal utilization of thrombo ...... n: concepts and controversies.
@nl
type
label
Optimal utilization of thrombo ...... n: concepts and controversies.
@en
Optimal utilization of thrombo ...... n: concepts and controversies.
@nl
prefLabel
Optimal utilization of thrombo ...... n: concepts and controversies.
@en
Optimal utilization of thrombo ...... n: concepts and controversies.
@nl
P1476
Optimal utilization of thrombo ...... n: concepts and controversies.
@en
P2093
P304
P356
10.1016/0735-1097(90)90482-5
P407
P577
1990-07-01T00:00:00Z